Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.44
Delayed Data
As of 4:00pm ET
 +0.01 / +0.41%
Today’s Change
1.00
Today|||52-Week Range
8.46
-4.31%
Year-to-Date

Today’s Trading

Previous close2.43
Today’s open2.44
Day’s range2.35 - 2.48
Volume429,056
Average volume (3 months)1,021,122
Market cap$177.3M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+29.14%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales26.71
Price/Book11.64

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...-0.01-0.08%
MDGNMedgenics Inc-0.13-1.79%
ANTHAnthera Pharmaceutic...-0.01-0.21%
RPRXRepros Therapeutics ...0.000.00%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers